President Zardari Visits Hunan Tea Group, Explores Bilateral Opportunities
April 26, 2026
Changsha, China: President Asif Ali Zardari visited Hunan Tea Group Co., Ltd., where he received a comprehensive briefing on the
Tag: Pakistan
Explore all our news . .
Recent Posts
President Zardari Visits Hunan Tea Group, Explores Bilateral Opportunities
April 26, 2026
Changsha, China: President Asif Ali Zardari visited Hunan Tea Group Co., Ltd., where he received a comprehensive briefing on the
President Zardari Meets Hunan Leaders to Bolster Cooperation in Key Sectors
April 26, 2026
Changsha, China: President Asif Ali Zardari, during his visit to Changsha in Hunan province, China, engaged in discussions with Hunan’s
President Zardari Meets Hunan Leaders to Bolster Cooperation in Key Sectors
April 26, 2026
Changsha, China: President Asif Ali Zardari, during his visit to Changsha in Hunan province, China, engaged in discussions with Hunan’s
Senator Khalil Tahir Sandhu Highlights Pakistan’s Role in Regional Peace at International Conference
April 26, 2026
Laie, Hawaii: Senator Khalil Tahir Sandhu emphasized Pakistan’s role in fostering regional peace and stability during his keynote address at
Senator Khalil Tahir Sandhu Highlights Pakistan’s Role in Regional Peace at International Conference
April 26, 2026
Laie, Hawaii: Senator Khalil Tahir Sandhu emphasized Pakistan’s role in fostering regional peace and stability during his keynote address at
Acting President Gilani Stresses Higher Education’s Role in Development during Meeting with University Leaders
April 26, 2026
Lahore: Acting President Syed Yousaf Raza Gilani met with Vice Chancellors from several universities, focusing on the transformative role of
Acting President Gilani Offers Condolences to Punjab Assembly Officials
April 26, 2026
Lahore: Acting President Syed Yousaf Raza Gilani on Sunday visited Punjab to meet with Punjab Assembly Speaker Malik Muhammad Ahmad
ROSEN, LEADING INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HUMA
November 21, 2024
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class
High-impact oil and gas exploration could cut global scope 1 and 2 emissions by 6% in 2030
November 21, 2024
Without creating new demand, new discoveries can help curb emissions, drive value for the industry LONDON and HOUSTON and SINGAPORE, Nov. 21, 2024 (GLOBE NEWSWIRE) — Investment in oil and gas exploration has plummeted two-thirds in the last decade, but the industry still has a critical role to play in
CGTN: ‘Golden partners’: China, Brazil seek a more just world, sustainable planet
November 21, 2024
BEIJING, Nov. 21, 2024 (GLOBE NEWSWIRE) — CGTN publishes an article on China and Brazil’s plans to seek a more just world and a sustainable planet. In 2014, the cooperation agreement between China and Brazil on the Belo Monte UHV transmission project was signed. The mega-project traverses a vast area,
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 21, 2024
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 20, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
November 20, 2024
Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
November 20, 2024
Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
November 20, 2024
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elanco Animal Health Incorporated (NYSE: ELAN) between November 7, 2023 and June 26, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead
LLAP DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Terran Orbital Corporation Investors to Secure Counsel Before Important November 26 Deadline in Securities Class Action – LLAP
November 20, 2024
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Terran Orbital Corporation (NYSE: LLAP) between August 15, 2023 and August 14, 2024, both dates inclusive (the “Class Period”), of the important November 26, 2024 lead plaintiff